Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation

Published:2010-08 Issue:8 Volume:16 Page:1107-1114
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Rizzieri David A.,Storms Robert,Chen Dong-Feng,Long Gwynn,Yang Yiping,Nikcevich Daniel A.,Gasparetto Cristina,Horwitz Mitchell,Chute John,Sullivan Keith,Hennig Therese,Misra Debashish,Apple Christine,Baker Megan,Morris Ashley,Green Patrick G.,Hasselblad Vic,Chao Nelson J.

Funder

Leukemia Lymphoma Society Clinical Scholar Award (D.A.R.), National Marrow Donor Program (D.A.N.), Adler Foundation (D.A.R. and D.M.)

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. Successful allogeneic engraftment of mismatched unrelated cord blood following non-myeloablative conditioning;Rizzieri;Blood,2001

2. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation;Childs;N Engl J Med,2000

3. Clinical outcome and immune reconstitution following Alemtuzumab T cell depleted mismatched non-myeloablative allogoneic immunotherapy;Rizzieri;J Clin Oncol,2007

4. Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma;Burroughs;Biol Blood Marrow Transplant,2008

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts;2024-05-14

2. Adoptive cellular therapy after hematopoietic stem cell transplantation;American Journal of Hematology;2024-01-25

3. Umbilical cord blood derived cellular therapy: advances in clinical development;Frontiers in Oncology;2023-05-18

4. The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients—a randomized trial;Leukemia;2023-03-17

5. Allogeneic Transplantation of Hematopoietic Stem Cells (HSCs) for Acute Leukemia in Children – Review of Literature and Experience of Single Center in Russia;Leukemia - From Biology to Clinic;2023-03-01